Niche opportunity Morari targets male sexual health with a wearable neuromodulation approach to delay ejaculation, presenting a distinct category in sexual wellness equipment. This opens doors for partnerships with urology clinics, sexual health researchers, and specialty retailers seeking innovative male enhancement solutions.

Clinical collaboration Existing or potential studies with San Diego Sexual Medicine indicate openness to clinical evaluation. This suggests sales prospects through research collaborations, pilot programs, and early-access partnerships to validate efficacy and drive clinician-backed adoption.

Product launch momentum Recent deployment of a new product MOR as of May 2026 demonstrates active go-to-market activity. Proactive outreach to retailers, direct-to-consumer channels, and healthcare distributors could capitalize on fresh market interest and early adopter demand.

Early-stage growth With a small team and revenue in the low millions, Morari represents a high-growth, low-penetration opportunity for strategic investors, contract manufacturers, and technology partners to scale production, regulatory processes, and global distribution.

Tech and compliance fit The blend of wearable hardware, neuromodulation tech, and consumer-facing software platforms aligns with medical device manufacturers and contract manufacturers seeking to expand in sexual health. There are avenues for OEM partnerships, regulatory assistance, and integration with telemedicine platforms.